Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$136,166,501
-$17,079,138 QoQ
Shares Held
113,526
-31.9% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
#332
of 4,605 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OP Asset Management Ltd holds $361,440,742 across 9 Drug Manufacturers - General names. LLY ranks #1 (37.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
113,526 | $136,166,501 | |
| 2 | JNJ |
Johnson & Johnson
|
268,770 | $68,259,516 | |
| 3 | ABBV |
AbbVie Inc.
|
197,569 | $49,716,263 | |
| 4 | MRK |
Merck & Co., Inc.
|
278,454 | $35,781,339 | |
| 5 | AMGN |
Amgen Inc
|
60,172 | $21,789,484 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
139,908 | $17,675,976 | |
| 7 | PFE |
Pfizer Inc
|
633,811 | $15,262,168 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,545 | $13,168,762 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,166,501 | 113,526 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $153,245,639 | 166,613 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $121,896,665 | 113,426 | Shares | Sole | 2026-04-21 | |
| 2025-09-30 | $73,653,153 | 96,531 | Shares | Sole | 2026-04-20 | |
| 2025-06-30 | $70,340,889 | 90,235 | Shares | Sole | 2026-04-20 | |
| 2025-03-31 | $73,548,111 | 89,051 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||